Serum antibodies in vitiligo patients

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Serum antibodies in vitiligo patients

Abstract

References

Autoimmune vitiligo: detection of antibodies to melanin-producing cells.

The screening test of various chemotherapeutic drugs in primary malignant melanoma cells and human malignant melanoma cell line (TM-1).

Vitiligo and autoimmune polyendocrine deficiencies with autoantibodies to melanin-producing cells

Should vitiligo be induced in patients after resection of primary melanoma.

T cell profiles in vitiligo

Antibodies to surface antigens of pigmented cells in animals with vitiligo

Correlation between vitiligo antibodies and extent of depigmentation in vitiligo

Prognosis of malignant melanoma

Vitiligo: peripheral T-cell subset imbalance as defined by monoclonal antibodies

Vitiligo, achlorhydria, and pernicious anaemia

Specific tissue and tumor responses of chimpanzees following immunization against human melanoma

Autoantibodies in patients with vitiligo

Vitiligo, thyroid disease and autoimmunity

Vitiligo and its aetiological relationship to organ-specific autoimmune disease

Antibodies to melanocytes in vitiligo

Antibodies to normal human melanocytes in vitiligo

Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study

Autoantibodies and their clinical significance in a black vitiligo population

Vitiligo in patients with metastatic melanoma: a good prognostic sign

Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study

Persistence of abnormal melanocytes in immunosuppressed chickens of the autoimmune "DAM" line

New regulators of melanin biosynthesis and the autodestruction of melanoma cells

Humoral immune response and expression of spontaneous postnatal amelanosis in DAM line chickens

Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin

Vitiligo. It is important

Prognosis in malignant melanoma

Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis

The oral tissues in vitiligo

Vitiligo in apparent dermatomal distribution

The syndrome of bazex or acrokeratosis paraneoplastica

Citations

The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions

Vitiligo and leukoderma in children

Pathophysiology of vitiligo

Vitiligo: where do we stand?

Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma.

Vitiligo

Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.

Association between Vitiligo and Thyroid Autoimmunity.

Prolactin levels in the patients with vitiligo

Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up

The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma

Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration

Assessment of the immune system in 55 Iranian patients with vitiligo

Vitiligo: auto-immunity and immune responses

Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?

Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males

Classification of vitiligo: a challenging endeavor

Colocalization of vitiligo and alopecia areata presenting as poliosis

Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines

Recent investigations on vitiligo vulgaris

Autoimmunity in vitiligo: relationship with HLA, Gm and Km polymorphisms

Prevalence of Thyroid Abnormalities in Thai Patients with Vitiligo

Vitiligo autoantibodies are effective against melanoma

Vitiligo: a manifestation of apoptosis?

Vitiligo. Pathogenesis and treatment

Interventions for vitiligo

Melanoma-associated hypopigmentation: where are the antibodies?

Evidence for an autoimmune pathogenesis of vitiligo

Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?

New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions

Vitiligo--part 1

Organ-specific autoantibodies in vitiligo patients and their relatives

Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism

Neural and Endocrinal Pathobiochemistry of Vitiligo: Comparative Study for a Hypothesized Mechanism

Adverse events during immunotherapy in Slovenian patients with metastatic melanoma reveal a positive correlation with better treatment outcomes.

Thioredoxin reductase in control of the pigmentary system

Vitiligo

Related Concepts

Related Feeds

Autoimmune Diseases

Related Papers

Correlation between vitiligo antibodies and extent of depigmentation in vitiligo

Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients

Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism

Therapeutic implications of autoimmune vitiligo T cells

Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells